Cargando…

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2

Objective: Chemotherapy is a major therapeutic method for bladder urothelial carcinoma (BUC), which can effectively improve the prognosis of BUC patients, but the chemoresistance often leads to chemotherapy failure. This study will research the regulatory roles and molecular mechanism of miR-101-3p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bo, Xie, Dalong, Zhang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584933/ https://www.ncbi.nlm.nih.gov/pubmed/31258770 http://dx.doi.org/10.7150/jca.33117

Ejemplares similares

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015)

EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c
por: Xu, Leibo, et al.
Publicado: (2020)

MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9
por: Jin, Qifang, et al.
Publicado: (2018)

Knockdown of microRNA-130b improves doxorubicin sensitivity in bladder urothelial carcinoma by negatively regulating cylindromatosis expression
por: Li, Bo, et al.
Publicado: (2019)

Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma
por: Xie, Dalong, et al.
Publicado: (2018)

Silencing of microRNA-101 prevents IL-1β-induced extracellular matrix degradation in chondrocytes
por: Dai, Linghui, et al.
Publicado: (2012)

MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C
por: Li, Guangyan, et al.
Publicado: (2021)

Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin
por: Javanmardi, Sanaz, et al.
Publicado: (2020)

MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
por: Okamura, Shunsuke, et al.
Publicado: (2021)

Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis
por: Lin, Tianyu, et al.
Publicado: (2019)

HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2
por: Ye, Yafei, et al.
Publicado: (2019)

Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis
por: Zhang, Huihui, et al.
Publicado: (2014)

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
por: Cao, Paul, et al.
Publicado: (2010)

MicroRNA-101 modulates cisplatin chemoresistance in liver cancer cells via the DNA-PKcs signaling pathway
por: Chai, Zongtao, et al.
Publicado: (2019)

Increased expression of EZH2 indicates aggressive potential of urothelial carcinoma of the bladder in a Chinese population
por: Zhou, Xiaozhou, et al.
Publicado: (2018)

Long Noncoding RNA RC3H2 Facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC
por: Wu, Kun, et al.
Publicado: (2020)

MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS
por: Long, Yongqi, et al.
Publicado: (2022)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
por: Berning, Lena, et al.
Publicado: (2021)

The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma
por: Banerjee, Rajat, et al.
Publicado: (2011)

MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1
por: Qian, Lu, et al.
Publicado: (2016)

Identification and functional analysis of risk-related microRNAs for the prognosis of patients with bladder urothelial carcinoma
por: Gao, Ji, et al.
Publicado: (2017)

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma
por: Mo, Miao, et al.
Publicado: (2021)

Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder
por: Singh, Pradeep, et al.
Publicado: (2022)

Author Correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
por: Garczyk, Stefan, et al.
Publicado: (2018)

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
por: Konno, Yosuke, et al.
Publicado: (2014)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5
por: Xu, Tianyuan, et al.
Publicado: (2016)

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
por: Inamoto, Teruo, et al.
Publicado: (2018)

Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
por: Shah, Amishi, et al.
Publicado: (2018)

MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
por: Sun, Xin-bo, et al.
Publicado: (2021)

Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition
por: Xin, Xiaofei, et al.
Publicado: (2019)

Prognostic significance of microRNA-101 in solid tumor: A meta-analysis
por: Ma, Xianxiong, et al.
Publicado: (2017)

MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers
por: Sun, Yue, et al.
Publicado: (2020)

MicroRNA-101a regulates microglial morphology and inflammation
por: Saika, Reiko, et al.
Publicado: (2017)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_shiv0sm665cumf5ncprucks7p6